PT94398A - Processo para preparacao de conjugados proteinicos magneticos - Google Patents

Processo para preparacao de conjugados proteinicos magneticos

Info

Publication number
PT94398A
PT94398A PT94398A PT9439890A PT94398A PT 94398 A PT94398 A PT 94398A PT 94398 A PT94398 A PT 94398A PT 9439890 A PT9439890 A PT 9439890A PT 94398 A PT94398 A PT 94398A
Authority
PT
Portugal
Prior art keywords
preparation
protein conjugates
cells
magnetic protein
removal
Prior art date
Application number
PT94398A
Other languages
English (en)
Other versions
PT94398B (pt
Inventor
Karlheinz Enssle
Peter Hermentin
Reiner Donges
Udo Franssen
Heinz-Jurgen Friesen
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT94398A publication Critical patent/PT94398A/pt
Publication of PT94398B publication Critical patent/PT94398B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • G01N2446/90—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids characterised by small molecule linker used to couple immunoreagents to magnetic particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT94398A 1989-06-19 1990-06-18 Processo para preparacao de conjugados proteinicos magneticos PT94398B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3919873A DE3919873A1 (de) 1989-06-19 1989-06-19 Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
PT94398A true PT94398A (pt) 1991-02-08
PT94398B PT94398B (pt) 1997-01-31

Family

ID=6382977

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94398A PT94398B (pt) 1989-06-19 1990-06-18 Processo para preparacao de conjugados proteinicos magneticos

Country Status (12)

Country Link
US (1) US5095097A (pt)
EP (1) EP0403961B1 (pt)
JP (1) JP2858883B2 (pt)
KR (1) KR0154120B1 (pt)
AT (1) ATE102052T1 (pt)
AU (1) AU639867B2 (pt)
CA (1) CA2019218C (pt)
DE (2) DE3919873A1 (pt)
DK (1) DK0403961T3 (pt)
ES (1) ES2063200T3 (pt)
IE (1) IE63666B1 (pt)
PT (1) PT94398B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007138A1 (en) 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
NO180658C (no) * 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5585278A (en) * 1994-10-27 1996-12-17 Bayer Corporation Method for coupling antibody to novel latex substrate and its use in immunoassay
WO1997014443A1 (en) * 1995-10-19 1997-04-24 Bracco International B.V. Magnetically labeled chemoattractants as targeted contrast agents in the nmr imaging of living tissues
NO961031D0 (no) 1996-03-13 1996-03-13 Det Norske Radiumshospital Tum Fremgangsmåte til å drepe uönskede målceller
JP4127724B2 (ja) * 1996-03-26 2008-07-30 サイレックス インコーポレーテッド リンパ球機能の測定方法
JP3662347B2 (ja) * 1996-06-10 2005-06-22 日鉄鉱業株式会社 医療用粉体
US6379975B1 (en) * 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
US7169571B2 (en) 1997-09-12 2007-01-30 Cylex, Inc. Methods for measurement of lymphocyte function
US6682940B2 (en) 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
NZ515852A (en) * 1999-05-04 2002-12-20 Dan A Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6828157B1 (en) 1999-05-04 2004-12-07 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US20020150952A1 (en) * 2001-04-17 2002-10-17 Peter Sottong Methods for measuring lymphocyte activation by mitogens and antigens

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334106A1 (fr) * 1975-12-02 1977-07-01 Pasteur Institut Gel magnetique convenant pour dosages immunoenzymatiques
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
NO155316C (no) 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
US4698302A (en) * 1983-05-12 1987-10-06 Advanced Magnetics, Inc. Enzymatic reactions using magnetic particles
US4554088A (en) * 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US4814098A (en) * 1986-09-06 1989-03-21 Bellex Corporation Magnetic material-physiologically active substance conjugate

Also Published As

Publication number Publication date
IE902194L (en) 1990-12-19
JP2858883B2 (ja) 1999-02-17
DE59004731D1 (de) 1994-04-07
IE902194A1 (en) 1991-01-02
EP0403961A3 (de) 1991-07-17
CA2019218C (en) 2001-01-02
ATE102052T1 (de) 1994-03-15
KR910000797A (ko) 1991-01-30
EP0403961B1 (de) 1994-03-02
DK0403961T3 (da) 1994-06-27
EP0403961A2 (de) 1990-12-27
JPH03184999A (ja) 1991-08-12
AU5717890A (en) 1990-12-20
PT94398B (pt) 1997-01-31
AU639867B2 (en) 1993-08-05
CA2019218A1 (en) 1990-12-19
KR0154120B1 (ko) 1998-10-15
US5095097A (en) 1992-03-10
DE3919873A1 (de) 1990-12-20
IE63666B1 (en) 1995-05-31
ES2063200T3 (es) 1995-01-01

Similar Documents

Publication Publication Date Title
PT94398A (pt) Processo para preparacao de conjugados proteinicos magneticos
GR3003047T3 (en) Fixation staple, especially for osteosynthesis, and process for its manufacture
BR9102832A (pt) Produto absorvente e metodo de fixar o mesmo
EP0224934A3 (en) Contrast agent, process for its preparation and its use for ultrasonic imaging
DK0458878T3 (da) Nyt monoklonalt antistof mod et nyt antigen, der er associeret med humane tumorer
DE3689941D1 (de) Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
PT969873E (pt) Hidrato de carbono glicopeptido antigene multiplo, vacina abrangendo o mesmo e seu uso
PT89307A (pt) Aplicador de infusao e processo de preparacao de composicoes a base de (mono)oxicloroseno ou de oxicloroseno de sodio para o mesmo
PT84370B (pt) Processo para a producao de anticorpos monoclonais e antigenios contra o carcinoma do pulmao humano do tipo celulas grandes e alguns outros carcinomas humanos
IE902195L (en) Magnetic protein conjugates
PT89963B (pt) Processo para a preparacao de conjugados de proteina magneticos e de meios de diagnostico que os contem
FR2601679B1 (fr) Immunotoxines, procede de preparation et compositions pharmaceutiques en contenant
DE3370026D1 (en) Biologically active conjugates and their preparation and use
ATE185150T1 (de) Proteinkomplex
ATE124706T1 (de) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben.
GB2250026A (en) Assays using albumin-tetrazolium interaction
EP0316764A3 (en) Detection of tumor-associated markers in biological fluids
HUT50989A (en) Method for detecting marek's virus in poultry
Deane et al. Characterisation of a putative MLR antigen
ES8605035A1 (es) Un procedimiento para producir un particula magnetica para inmovilizacion de proteinas biologicas.
SE8902061D0 (sv) Kateter med invaendigt utbytbar yta
ES2002532A6 (es) Procedimiento para la preparacion de un complejo inmunogenico
RO85246A3 (ro) Procedeu de preparare a antigenului citomecanic uman

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19961015

PC3A Transfer or assignment

Free format text: 19981125 BEHRING DIAGNOSTICS GMBH DE

PD3A Change of proprietorship

Owner name: DADE BEHRING MARBURG GMBH

Effective date: 19981125

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020430